News
- Author:
- Christine Kilgore
Publish date: November 10, 2023
Findings could guide clinical decision making for starting immunosuppression in patients with a history of malignancy.
News
- Author:
- Christine Kilgore
Publish date: November 8, 2023
Patients failing two or more biologic agents of different mechanistic classes “are really suffering. We need to have better guidelines and treatmen...
News
- Author:
- Christine Kilgore
Publish date: October 24, 2023
Researchers described ongoing work to “understand the discrete and overlapping endotypes that underlie the phenotypes” of psoriatic disease and to ...
News
- Author:
- Christine Kilgore
Publish date: October 19, 2023
Targeting resident memory T cells may be a key to long-term remission.
News
- Author:
- Christine Kilgore
Publish date: October 11, 2023
AD and ACD both present with red, itchy, eczema-like patches and plaques and can be “really hard to differentiate.”
News
- Author:
- Christine Kilgore
Publish date: September 15, 2023
Screening family members takes hold in PF; genetic discoveries deepen understanding of primary ciliary dyskinesia.
News
- Author:
- Christine Kilgore
Publish date: August 1, 2023
The program "is meant to be a stepping point for initiating care ... to set someone up for success for recurrent telehealth visits in the future."<...
News
- Author:
- Christine Kilgore
Publish date: July 20, 2023
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis ...
News
- Author:
- Christine Kilgore
Publish date: July 20, 2023
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the path...
News
- Author:
- Christine Kilgore
Publish date: July 10, 2023
It’s “likely the case” that the pathobiome – with the gut bacteria Ruminococcus blautia gnavus being an important pathobiont – helps to dr...
News
- Author:
- Christine Kilgore
Publish date: June 14, 2023
“Should management be tailored for people with HIV infection?”
News
- Author:
- Christine Kilgore
Publish date: June 12, 2023
Dupilumab dosing and dupilumab-associated facial redness and ocular disease, self-image issues, topical regimen adherence, and the quantification o...
News
- Author:
- Christine Kilgore
Publish date: June 5, 2023
The analysis stratified patients by age – 18-50 and over 50 years – and found that the sustained improvement with the JAK-1 selective inhibitor as ...
News
- Author:
- Christine Kilgore
Publish date: June 5, 2023
Other recent research on the biologic has shown that it improves lesional skin barrier function and rapidly reduces the abundance of Staphyloco...
News
- Author:
- Christine Kilgore
Publish date: May 30, 2023
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
